INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-13 Cr | ₹1.42 Cr | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹1.42 Cr |
| Mar2024 | ₹-4.58 Cr |
| Mar2023 | ₹0.53 Cr |
| Mar2022 | ₹2.91 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹1.42 Cr | Positive | |
| Mar2024 | ₹-4.58 Cr | Negative | |
| Mar2023 | ₹0.53 Cr | -81.91 | |
| Mar2022 | ₹2.91 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹173.7 Cr | 27.2% | 7.4% | -41.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,607.9 Cr | -4.4% | -13% | -35.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,221.9 Cr | -3.3% | -4.5% | 10.5% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,393.4 Cr | 3.7% | -1.2% | 30.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹883.1 Cr | -5.1% | -4.4% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹587.6 Cr | 4.5% | 11.6% | 15% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 27.2% |
7.4% |
-41.5% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses